Company Profile
CEO
Mr. Stéphane Bancel M.B.A.(CEO & Director)
Sector
Healthcare
Industry
Biotechnology
Employees
4.7K
Beta
1.03
Forward P/E
-11.3
52W High
$59.55
52W Low
$22.28
Profit Margin
-143.6%
Operating Margin
-131.1%
Return on Equity
-36.6%
Revenue Growth
260.2%
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise c...
Valuation
Market Cap$18.89B
P/E (TTM)--
P/S (TTM)12.14
EV/EBITDA--
Cash Flow
FCF Yield-14.7%
SBC Adj. FCF Yield-16.9%
SBC Impact15.0%
Margins & Growth
Profit Margin-345.2%
Operating Margin-356.8%
Revenue YoY260.2%
Earnings YoY--
Balance
Cash$1.91B
Debt$590.00M
Net Cash$1.32B
Dividend
Dividend Yield--
Payout Ratio--
Quarterly Payout--